Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) as an add-on ...

Yuvanci (single tablet combination therapy [STCT] of macitentan and tadalafi) has been approved by the European Commission ...

Public health, access to healthcare services, and food and nutrition are some of the most important issues facing people ...

Johnson & Johnson (J&J) and Legend Biotech have shared positive long-term results for their BCMA-directed T-cell ...

Women have played a crucial role in rare disease awareness and better care, overcoming gender biases and systemic challenges ...

Many initiatives have tried to address this partnership challenge: the Healthcare Communications Association’s (HCA) own ...

The British Skin Foundation’s (BSF) skin research programme has received a £10,000 donation from Circle Health Group (CHG) ...

Yesterday marked World Heart Day, and Medscape is at the forefront with a featured article in Media Planet's cardiology ...

Eli Lilly has announced that it is investing $4.5bn into a new US facility for advanced manufacturing and drug development. The Lilly Medicine Foundry will give the company the ability to research new ...

This Blood Cancer Awareness Month, we want to highlight the critical role of patient-centricity in building awareness, ...

NHS England has announced that hundreds of babies have begun to be tested for over 200 genetic conditions as part of a study led by Genomics England. The Generation Study is evaluating the potential ...

Astellas Pharma’s claudin 18.2-directed cytolytic antibody has been approved by the European Commission (EC) as part of a first-line combination treatment for a subset of gastric cancer patients.